Literature DB >> 15851631

Thyrotoxicosis caused by weight-reducing herbal medicines.

Hidemi Ohye1, Shuji Fukata, Maki Kanoh, Sumihisa Kubota, Kanji Kuma, Akira Miyauchi, Masahiro Sugawara.   

Abstract

The weight-reducing herbal medicines "Dream Shape" and "Ever Youth" became available in Japan in 2000. Herein, we describe 12 patients who developed thyrotoxicosis after taking them. The thyroid hormone content of 1 capsule or tablet of herbal medicine, measured following Pronase digestion and ethanol extraction, was approximately 1 mug of triiodothyronine and 3 to 4 mug of thyroxine. Two of us took 10 capsules or tablets of Dream Shape or Ever Youth, and changes in thyroid hormone levels were observed during the first 24 hours. Serum free triiodothyronine levels began to rise 2 hours after ingestion and reached peak levels at 4 to 8 hours; changes in free thyroxine and thyrotropin levels were small during the first 24 hours. Similar herbal medicines may have been distributed to other countries via the Internet. Resultant factitious thyrotoxicosis can create diagnostic and therapeutic confusion, particularly in patients with thyroid disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15851631     DOI: 10.1001/archinte.165.8.831

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Case series on a diversity of illicit weight-reducing agents: from the well known to the unexpected.

Authors:  Magdalene H Y Tang; Sammy P L Chen; Sau W Ng; Albert Y W Chan; Tony W L Mak
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

2.  Potential risks associated with the use of herbal anti-obesity products.

Authors:  Thomas Y K Chan
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

3.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 4.  Current evidence for the treatment of hypothyroidism with levothyroxine/levotriiodothyronine combination therapy versus levothyroxine monotherapy.

Authors:  James V Hennessey; Ramon Espaillat
Journal:  Int J Clin Pract       Date:  2018-01-30       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.